newsfilter
← Latest News
GlobeNewswire·

Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate

MONT-SAINT-GUIBERT, Belgium, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA ((Euronext &, NASDAQ:CYAD) ("Celyad" or the "Company"), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cel